-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Unity Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
- Unity Biotechnology, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.6M, a 54.7% increase year-over-year.
- Unity Biotechnology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28.9M, a 42.3% increase year-over-year.
- Unity Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$44.7M, a 22.4% increase from 2022.
- Unity Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$57.6M, a 1.6% decline from 2021.
- Unity Biotechnology, Inc. annual Operating Income (Loss) for 2021 was -$56.7M, a 39.7% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)